INOV8 Logo



Dr. Peter Corr

Dr. Peter B. Corr, Principal

Contact information:

Office: 908-546-6107

A University of the Virgin Islands Research and Technology Park Corporation

General Description Of Company

INOV8, LLC is part of the University of the Virgin Islands Research and Technology Park. INOV8 provides investment capital, management oversight and medical, pharmaceutical, venture capital and private equity consulting services to a variety of enterprises in the United States and internationally. INOV8 is engaged in both advising existing entities and helping to fund and start new enterprises. In the latter case, INOV8 identifies an aspiring entrepreneur who wishes to start a new business. INOV8 applies its wealth of venture capital and private equity experience, knowledge of science, medicine and pharmaceuticals, and information networks to help the entrepreneur to think through his or her business plan, operating and start-up budgets, and proposed capital structure. INOV8 also carries out in-depth due diligence on all aspects of the business opportunity, as well as the background of the entrepreneur. INOV8 provides angel capital to help the business get started. INOV8 primarily makes its capital investments in partnership with other investors although in certain cases it may initially invest alone. INOV8 receives fee income for the services it provides, and capital appreciation on its investments. In addition, if asked, INOV8 serves as a director or as Chairman of client companies' Boards and INOV8 receives fees for so doing. INOV8 may also receive equity ownership in its investments in lieu of or in addition to fees and may offer financing structures to other investors in its venture capital and private equity investments.

INOV8 and Dr. Peter B. Corr, the Principal of INOV8, LLC, offer the RTPark program generally, and UVI particularly, the opportunity to expand its academic breadth by aiding the UVI in its establishment and funding of a medical school. INOV8 brings consulting and venture capital investment knowledge in pharmaceuticals, science and medicine to the Territory. By working with INOV8 through the RTPark program, the University opens itself to direct collaboration with this resource. The focus for the intern would include four areas:

  1. The Research and Development (“R&D”) process for new medicines or medical devices
  2. The process of Translational Medicine – from lab bench to bedside
  3. Entrepreneurship in Biology and Medicine
  4. Leadership at different levels of a Company and what is required at each stage

The intern will work directly with Dr. Corr at INOV8 with regard to reviewing and designing clinical protocols for clinical trials in several therapeutic disease areas. Interns will be involved in all aspects of the development of medicines including regulatory requirements, manufacturing of clinical supplies and implementation of clinical trials to test the drugs under study for both safety and efficacy. This would start with pre-clinical studies then move to clinical studies through various phases – phase 1, phase 2 and, finally, phase 3. This internship involves one-on-one learning with hands-on work with leaders in their respective fields.